Skip to content

A Pilot Study to Determine a Candidate Protocol for Transcranial Electrical Stimulation in the Treatment of Anxiety

Optimizing Transcranial Electrical Stimulation for Clinical Applications (the OptES Study): A Pilot Study to Determine a Candidate Protocol for Treatment of Anxiety (OptES-Anx)

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02321891
Enrollment
14
Registered
2014-12-22
Start date
2014-12-31
Completion date
2015-12-31
Last updated
2014-12-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety

Brief summary

The investigators examine the efficacy of two different transcranial direct current stimulation (tDCS) stimulation protocols in the treatment of anxiety in an open-label pilot study.

Detailed description

The investigators examine the efficacy of two different transcranial direct current stimulation (tDCS) stimulation protocols in the treatment of anxiety in an open-label pilot study in patients with chronic pain. The investigators also seek to detect autonomic nervous system changes induced by the tDCS, and develop new methods for the measurement of autonomic nervous system functions.

Interventions

DEVICENeuroConn DC Stimulator Plus, tDCS

transcranial electrical stimulation intervention with two experimental protocols

Sponsors

University of Eastern Finland
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Age 18-65 years * Naïve to tDCS * Right-handed * Beck Anxiety Scores \>= 26

Exclusion criteria

* Metal implants inside skull or eye * Severe skin lesions at the electrode placement area * History of epilepsy or previous seizures * Pregnant or breast-feeding * Pacemaker * History of intracerebral bleeding during the past six months * Lifetime DSM-IV diagnosis of bipolar mood disorder or psychotic disorder * DSM-IV diagnosis for substance abuse or dependence during the past six months

Design outcomes

Primary

MeasureTime frameDescription
Beck Anxiety Inventory12 dayschange in scores of anxiety

Countries

Finland

Contacts

Primary ContactSoili M Lehto, MD, PhD
soili.lehto@kuh.fi+358 44 717 2971

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026